BRIM Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	721.9	502.76	948	837.99	399.75	83.03
Short-Term Investments	560	1,346	747.63	-	23.84	86.42
Cash & Short-Term Investments	1,282	1,849	1,696	837.99	423.59	169.45
Cash Growth	-12.49%	9.03%	102.34%	97.83%	149.98%	-60.90%
Other Receivables	12.46	10.01	6.24	0.45	0.37	0.63
Receivables	12.66	10.01	6.24	0.45	0.37	0.63
Prepaid Expenses	39.27	17.43	11.1	10.55	6.65	6.16
Total Current Assets	1,335	1,876	1,713	848.99	430.61	176.24
Property, Plant & Equipment	16.86	11.79	6.37	7.99	3.62	6.39
Long-Term Investments	26.95	38.27	57.3	82.33	60.35	134.07
Other Intangible Assets	459.73	483.39	1.34	0.09	-	-
Other Long-Term Assets	2.05	1.02	0.7	0.59	0.86	0.59
Total Assets	1,934	2,411	1,779	939.99	495.44	317.28
Accrued Expenses	30.14	15.52	36.04	16.99	12.34	44.99
Current Portion of Leases	7.35	4.23	3.48	3.63	2.85	3.58
Current Unearned Revenue	1	-	-	-	-	1.12
Other Current Liabilities	4.73	331.08	2.52	1.87	2.05	1.14
Total Current Liabilities	48.76	350.84	42.05	22.48	17.23	50.82
Long-Term Leases	1.94	3.54	0.11	2.81	0.32	2.64
Total Liabilities	57.65	354.38	42.16	25.3	17.55	53.46
Common Stock	1,332	1,315	1,158	932.54	692.54	588.86
Additional Paid-In Capital	1,135	1,435	1,555	589.72	454.31	232.36
Retained Earnings	-859.69	-884.69	-1,149	-771.19	-746.92	-641.47
Comprehensive Income & Other	196.69	191.41	173.56	163.63	77.96	84.07
Total Common Equity	1,804	2,056	1,737	914.69	477.89	263.82
Minority Interest	73.04	-	-	-	-	-
Shareholders' Equity	1,877	2,056	1,737	914.69	477.89	263.82
Total Liabilities & Equity	1,934	2,411	1,779	939.99	495.44	317.28
Total Debt	21.14	7.78	3.59	6.44	3.16	6.22
Net Cash (Debt)	1,261	1,841	1,692	831.55	420.42	163.23
Net Cash Growth	-13.90%	8.80%	103.48%	97.79%	157.57%	-62.08%
Net Cash Per Share	9.77	15.78	16.83	11.66	7.09	2.77
Filing Date Shares Outstanding	133.21	131.5	115.75	93.25	69.25	58.89
Total Common Shares Outstanding	133.21	131.5	115.75	93.25	69.25	58.89
Working Capital	1,286	1,525	1,671	826.51	413.38	125.42
Book Value Per Share	13.54	15.64	15.00	9.81	6.90	4.48
Tangible Book Value	1,250	1,573	1,735	914.6	477.89	263.82
Tangible Book Value Per Share	9.38	11.96	14.99	9.81	6.90	4.48
Machinery	14.61	9.12	6.46	4.84	3.59	4.23
Leasehold Improvements	3.67	3.67	3.44	3.19	3.07	3.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.